2024, Number 1
Predictors of intrahospital mortality in patients with coronavirus disease 2019 and cerebrovascular diseases: rapid systematic review and meta-analysis protocol
Full text
Language: English
References: 42
Page: 27-34
PDF size: 200.31 Kb.
ABSTRACT
Background: The coronavirus disease 2019 (COVID19) is a novel pandemic disease caused by the β-coronavirus SARS-CoV-2. This disease affects primarily the respiratory organs, but it may also affect the vascular system. COVID19 may lead to either coagulopathies or hemorrhagic disorders involving the central nervous system. Risk factors for a fatal outcome have been suggested but not completely elucidated.Objectives: This systematic review protocol aims to identify clinical, imaging, and laboratory variables associated with intra-hospital mortality in patients with COVID19 and cerebrovascular disease.
Materials and Methods: Studies will be retrieved from Web of Science, MEDLINE, Scopus, EBSCOhost, Ovid, Rayyan’s COVID-19 Open Research Dataset, and Google Scholar. Inclusion criteria will be observational studies or clinical trials describing patients with both COVID19 and cerebrovascular disease. Exclusion criteria will be studies whose patients remained hospitalized with no defined outcome (intrahospital mortality or discharge), studies written in languages different from English, published before 2019 or in case the full text could not be retrieved. All demographic, laboratory and imaging variables will be extracted. Data synthesis will be presented in graphs, figures, and summary of findings tables. A global mortality rate will be calculated. A narrative synthesis will be included. A meta-analysis will be performed. For mortality rate and statistical synthesis, only studies reporting the main outcome (intra-hospital mortality or discharge) will be considered. Quality of the evidence will be assessed using the JBI Critical Appraisal tools. This protocol received no funding and is registered in PROSPERO.
REFERENCES
2019: incidence, risk factors, and pathogenesis - a systematic reviewand meta-analysis. F1000Research. 2021;10:34.2. Bhatti AUR, Zreik J, Yolcu YU, Alvi MA, Abode-Iyamah K, Quinones-Hinojosa A, Bydon M. Nervous System Involvement in SARS-Coronavirusinfection: A Review on Lessons Learned from the Previous Outbreaks,Ongoing Pandemic and What to Expect in the Future. Int J Neurosci.2021
Chou SH-Y, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V,Mainali S, Bassetti C, Suarez JI, McNett M, Nolan L, Temro K, Cervantes-Arslanian AM, Anand P, Mukerji S, Alabasi H, Westover MB, Kavi T, JohnS, Da Silva I, Shaik A, Sarwal A, Izzy S, Liotta EM, Batra A, Aysenne A,Rubinos C, Azzam AY, Azab MA, Sandall J, Persondek LM, Ulmer H,Rass V, Pfausler B, Müller C, Jung S, Crean M, Meoni S, Bereczki D,Kovács T, Agajany N, Armon C, Wolfson S, Cotelli MS, BianchiE, Riahi A, Öztürk S, Ural O, Viktoriia G, Lesiv M, Maia L, OliveiraV, Seabra M, Carvalho V, Vespa P, Provencio J, Olson D, Hemphill C,Venkatasubba Rao CP, Ko N, Fink E, Robertson C, Schober M, SmithScott A, Hammond M, Paul N, Safonova A, Kaplan L, Ratnayake C,Sharma AD, Skeel A, Villamizar Rosales C, Dolak D, Varelas P, LotmanL, Kaltenbach L, David K. M, GCS-NeuroCOVID CAENERGYC. GlobalIncidence of Neurological Manifestations Among Patients HospitalizedWith COVID-19—A Report for the GCS-NeuroCOVID Consortium andthe ENERGY Consortium. JAMA Network Open. 2021;4(5):e2112131.
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, MulrowCD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J,Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E,McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, WelchVA, Whiting P, McKenzie JE. PRISMA 2020 explanation and elaboration:updated guidance and exemplars for reporting systematic reviews. BMJ.2021;372:n160.
Polhemus AM, Bergquist R, Bosch de Basea M, Brittain G, Buttery SC,Chynkiamis N, Dalla Costa G, Delgado Ortiz L, Demeyer H, EmmertK, Garcia Aymerich J, Gassner H, Hansen C, Hopkinson N, KluckenJ, Kluge F, Koch S, Leocani L, Maetzler W, Micó-Amigo ME, MikolaizakAS, Piraino P, Salis F, Schlenstedt C, Schwickert L, Scott K, SharrackB, Taraldsen K, Troosters T, Vereijken B, Vogiatzis I, Yarnall A, MazzaC, Becker C, Rochester L, Puhan MA, Frei A. Walking-related digitalmobility outcomes as clinical trial endpoint measures: protocol for ascoping review. BMJ Open. 2020;10(7):e038704.